News by Industry
Biotechnology
Releases published in the last 30 days.
Page 1 of 2
- European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancer
- 11/20/2009 11:05:10 AM
- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Committee for Medicinal Products for Human Use (CHMP), which is responsible for conducting the initial assessment of medicinal products that...
- Steve DeMorro Named Vice President of Human Resources, Recruitment, and Healthcare Education at Publicis Strategic Solutions Group
- 11/19/2009 11:20:19 AM
- LAWRENCEVILLE, N.J.—November 19, 2009—Publicis Strategic Solutions Group—a leading provider of multichannel message delivery solutions for the life sciences industry—has announced that Steve DeMorro h...
- Improving Quality, Cost-Effectiveness, and Time Savings in Preclinical Inhalable Formulation Development
- 11/18/2009 9:49:07 AM
- In today’s fast growing inhalables market, the availability of suitable, efficient and cost-effective means of gathering particle analysis data for pulmonary formulation is clear. At this year’s Drug...
- In-solution Method for Streamlining Next-Generation Genome Sequencing Shown to be Uniform, Reproducible across Many Samples
- 11/18/2009 9:18:54 AM
- SANTA CLARA, Calif., Researchers from the Moores University of California San Diego (UCSD) Cancer Center, The Scripps Institute, and Agilent Technologies Inc. (NYSE: A) have shown that "solution enric...
- Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform
- 11/18/2009 9:16:13 AM
- Abbott Park, Illinois and Waltham, Massachusetts, — Abbott (NYSE: ABT) and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may pl...
- Boehringer Ingelheim and GlaxoSmithKline back EFA`s call for urgent improvements in care for people with lung disease this World COPD Day
- 11/18/2009 9:11:54 AM
- Brussels, Ingelheim and London - Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have today an...
- Novartis Influenza A(H1N1) 2009 vaccine US interim data show lower doses of antigen may suffice to generate a protective immune response against A(H1N1)
- 11/17/2009 10:28:57 AM
- * Interim clinical data from approximately 4,000 individuals suggest that half a dose of the currently US-approved Novartis unadjuvanted Influenza A(H1N1) 2009 vaccine met immunogenicity criteria in a...
- GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction
- 11/16/2009 11:07:21 AM
- Upfront and potential consideration of over $500 million London UK, Rockville US - GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) today announced an exclusive worldwide opt...
- Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care
- 11/15/2009 11:23:18 AM
- WHITEHOUSE STATION, N.J. - Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a r...
- Low Birth Weight and Diabetes Have a Common Genetic Background
- 11/12/2009 10:43:37 AM
- Neuherberg - Low birth weight increases the risk of developing type 2 diabetes later in life. Until recently scientists had attributed this to maternal malnutrition during pregnancy. However, now it s...
- Hebrew University researchers discover mechanism of insulin production that can lead to better treatment for diabetes
- 11/12/2009 10:40:42 AM
- How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universitie...
- Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
- 11/12/2009 10:08:01 AM
- Anti-NGF Compound Adds to Company’s Early-Stage Pain Care Pipeline Abbott Park, Illinois (NYSE: ABT) — Abbott announced today a definitive agreement to acquire the global rights to PanGenetics BV’s...
- Evotec and Boehringer Ingelheim Extend and Broaden Research Collaboration
- 11/9/2009 10:03:59 AM
- Strategic research collaboration continues for another 4 years at a value of EUR 15 million plus milestones and royalties Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT; TecDAX, NASDA...
- Scientists at TU Braunschweig and DeveloGen AG receive Phoenix Science Award 2009 for a publication in the field of beta cell regeneration
- 11/9/2009 9:53:09 AM
- Goettingen, Germany — DeveloGen AG, a biotechnology company focused on the discovery and development of novel therapies for diabetes and other metabolic and endocrine disorders announced today that a ...
- Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)
- 11/9/2009 9:38:59 AM
- London UK - GlaxoSmithKline (GSK) today announced the results from the clinical trial assessing Pandemrix™, GSK’s adjuvanted H1N1 pandemic influenza vaccine, administered at the same time as the annua...
- World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine
- 11/8/2009 11:53:12 AM
- First prequalification for pneumococcal disease vaccine - a life-threatening disease affecting many children; follows first-ever World Pneumonia Day London UK - The World Health Organization (WHO) ...
- First report of using radiolabeled antibodies and stem cell transplantation to successfully treat advanced leukemia
- 11/7/2009 1:07:56 PM
- SEATTLE — For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell tra...
- New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
- 11/6/2009 10:51:39 AM
- New Haven, Conn. — Researchers at Yale University have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer cells....
- A ‘Spectroscopist’s Dream’ Captures the Imagination of Journal Readers
- 11/4/2009 4:13:07 PM
- An article describing structure elucidation methods using NMR achieves status as one of the top 10 most accessed articles in the Journal of Cheminformatics. Toronto, Canada (November 4, 2009) — An...
- New Merck Begins Operations
- 11/4/2009 12:01:59 PM
- * With Robust Pipeline, Broader Product Portfolio and Expanded Global Presence WHITEHOUSE STATION, N.J.– Merck & Co., Inc. (NYSE: MRK) today outlined its global plans following the completion of M...